Skip to content
Disclosery

BML Capital Management, LLC

Follow

13F filer, CIK 1616824, ZIONSVILLE, IN

BML Capital Management, LLC reported $176,054,067 across 18 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-07. Its ten largest share positions make up 93.8% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001754960-26-000696

Period
2026-06-30
Reported value
$176M
Holdings
18
Top 10 weight
93.8%
New
3
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ENGNnew+6,669,908$11.5M
KHCadded+340,000$8.03M
OMadded+617,500$2.67M
KMXadded+17,500$926K
CNTBadded+164,400$391K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ACRSreduced-2,275,000-$12M
ORMPreduced-2,300,962-$11.1M
KZRexited-720,787-$5.35M
AVIRreduced-106,327-$494K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001754960-26-000696, largest first. % of portfolio is the value over $175,099,979, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 14,250,000 shares; 2024Q4: 14,250,000 shares; 2025Q1: 14,250,000 shares; 2025Q2: 14,250,000 shares; 2025Q3: 14,250,000 shares; 2025Q4: 14,250,000 shares; 2026Q1: 14,250,000 shares; 2026Q2: 11,975,000 shares 11,975,000$63.3M36.18%-2,275,000Timeline
AVIRATEA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 6,650,000 shares; 2024Q4: 7,608,312 shares; 2025Q1: 7,609,812 shares; 2025Q2: 7,609,812 shares; 2025Q3: 7,473,963 shares; 2025Q4: 7,490,000 shares; 2026Q1: 7,058,657 shares; 2026Q2: 6,952,330 shares 6,952,330$32.3M18.46%-106,327Timeline
ENGNENGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,669,908 shares 6,669,908$11.5M6.59%newTimeline
KHCKRAFT HEINZ COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 125,000 shares; 2026Q2: 465,000 shares 465,000$11M6.27%+340,000Timeline
OMOUTSET MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 543,180 shares; 2026Q1: 1,902,201 shares; 2026Q2: 2,519,701 shares 2,519,701$10.9M6.22%+617,500Timeline
KMXCARMAX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 155,000 shares; 2026Q1: 155,000 shares; 2026Q2: 172,500 shares 172,500$9.12M5.21%+17,500Timeline
TLYSTILLYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,150,000 shares; 2026Q2: 2,150,000 shares 2,150,000$9.03M5.16%0Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,688,772 shares; 2024Q4: 3,466,684 shares; 2025Q1: 3,747,612 shares; 2025Q2: 5,000,000 shares; 2025Q3: 5,292,000 shares; 2025Q4: 5,292,000 shares; 2026Q1: 5,320,000 shares; 2026Q2: 5,330,000 shares 5,330,000$7.14M4.08%+10,000Timeline
TILINSTIL BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 335,000 shares; 2024Q4: 400,000 shares; 2025Q1: 416,720 shares; 2025Q2: 534,899 shares; 2025Q3: 645,600 shares; 2025Q4: 645,600 shares; 2026Q1: 645,600 shares; 2026Q2: 645,600 shares 645,600$4.96M2.84%0Timeline
TGTTARGET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,000 shares; 2025Q4: 37,500 shares; 2026Q1: 37,500 shares; 2026Q2: 37,500 shares 37,500$4.9M2.8%0Timeline
ORMPORAMED PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,186,191 shares; 2024Q4: 2,643,907 shares; 2025Q1: 3,020,748 shares; 2025Q2: 3,083,253 shares; 2025Q3: 3,167,231 shares; 2025Q4: 3,167,231 shares; 2026Q1: 3,167,231 shares; 2026Q2: 866,269 shares 866,269$4.17M2.38%-2,300,962Timeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 154,961 shares; 2026Q2: 154,961 shares 154,961$2.38M1.36%0Timeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,546,137 shares; 2026Q1: 1,546,137 shares; 2026Q2: 1,546,137 shares 1,546,137$1.76M1.01%0Timeline
CNTBCONNECT BIOPHARMA HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,267,500 shares; 2025Q4: 408,887 shares; 2026Q1: 408,887 shares; 2026Q2: 573,287 shares 573,287$1.36M0.78%+164,400Timeline
IMAIMAGENEBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 182,509 shares; 2025Q4: 177,026 shares; 2026Q1: 200,730 shares; 2026Q2: 200,730 shares 200,730$1.18M0.68%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
WMTWALMART INC COMput335$386K0
CORZCORE SCIENTIFIC INC NEW COMput800$298Knew
TSLATESLA INC COMput375$270Knew

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
KZRKEZAR LIFE SCIENCES INC720,787$5.35Mshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001754960-26-000696 base2026-08-07acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001754960-26-000696 Quarter ended 2026-06-302026-08-07acceptance time not in the bulk data set
13F-HR 0001754960-26-000359 Quarter ended 2026-03-312026-05-06acceptance time not in the bulk data set
13F-HR 0001754960-26-000146 Quarter ended 2025-12-312026-02-03acceptance time not in the bulk data set
13F-HR 0001754960-25-000762 Quarter ended 2025-09-302025-11-10acceptance time not in the bulk data set
13F-HR 0001754960-25-000555 Quarter ended 2025-06-302025-08-11acceptance time not in the bulk data set
13F-HR 0001754960-25-000280 Quarter ended 2025-03-312025-05-07acceptance time not in the bulk data set
13F-HR 0001754960-25-000111 Quarter ended 2024-12-312025-02-07acceptance time not in the bulk data set
13F-HR 0001754960-24-000545 Quarter ended 2024-09-302024-11-05acceptance time not in the bulk data set
13F-HR 0001754960-24-000403 Quarter ended 2024-06-302024-08-07acceptance time not in the bulk data set
13F-HR/A 0001754960-24-000178 Quarter ended 2024-03-312024-04-24acceptance time not in the bulk data set
13F-HR 0001754960-24-000175 Quarter ended 2024-03-312024-04-23acceptance time not in the bulk data set
13F-HR/A 0001754960-24-000074 Quarter ended 2023-12-312024-02-02acceptance time not in the bulk data set
13F-HR 0001754960-24-000064 Quarter ended 2023-12-312024-01-30acceptance time not in the bulk data set
13F-HR 0001754960-23-000287 Quarter ended 2023-09-302023-10-23acceptance time not in the bulk data set
13F-HR 0001754960-23-000204 Quarter ended 2023-06-302023-07-24acceptance time not in the bulk data set
13F-HR 0001754960-23-000107 Quarter ended 2023-03-312023-04-14acceptance time not in the bulk data set
13F-HR 0001754960-23-000073 Quarter ended 2022-12-312023-02-13acceptance time not in the bulk data set